Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail

[1]  Donald E Ingber,et al.  Organ‐on‐Chip Recapitulates Thrombosis Induced by an anti‐CD154 Monoclonal Antibody: Translational Potential of Advanced Microengineered Systems , 2018, Clinical pharmacology and therapeutics.

[2]  Christopher P. Austin,et al.  Recommendations toward a human pathway-based approach to disease research. , 2018, Drug discovery today.

[3]  James Wilsdon,et al.  The biomedical bubble , 2018 .

[4]  Guy Beauchamp,et al.  ARRIVE has not ARRIVEd: Support for the ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines does not improve the reporting quality of papers in animal welfare, analgesia or anesthesia , 2018, PloS one.

[5]  Silvia Casati,et al.  Integrated Approaches to Testing and Assessment , 2018, Basic & clinical pharmacology & toxicology.

[6]  Gordana Vunjak-Novakovic,et al.  Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development. , 2018, Cell stem cell.

[7]  GanWeiniu.  Interview with a Thought Leader on Systems Medicine—Weiniu Gan, PhD , 2018 .

[8]  Bernhard Voelkl,et al.  Reproducibility of preclinical animal research improves with heterogeneity of study samples , 2018, PLoS biology.

[9]  M. Enserink.  Sloppy reporting on animal studies proves hard to change. , 2017, Science.

[10]  Oliver J. Britton,et al.  Human In Silico Drug Trials Demonstrate Higher Accuracy than Animal Models in Predicting Clinical Pro-Arrhythmic Cardiotoxicity , 2017, Front. Physiol..

[11]  T. Murphy,et al.  Enhancing the alignment of the preclinical and clinical stroke recovery research pipeline: Consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable translational working group , 2017, International journal of stroke : official journal of the International Stroke Society.

[12]  P. Sandercock,et al.  Controversies in Thrombolysis , 2017, Current Neurology and Neuroscience Reports.

[13]  Zhanmin Lin,et al.  Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 , 2017, Science.

[14]  Ben Goldacre,et al.  Why clinical trial outcomes fail to translate into benefits for patients , 2017, Trials.

[15]  Espen A. Sjoberg.  Logical fallacies in animal model research , 2017, Behavioral and Brain Functions.

[16]  H. Allore,et al.  Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson’s disease , 2017, PloS one.

[17]  Bo Wang,et al.  Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results. , 2016, JAMA internal medicine.

[18]  R. Harrison,et al.  Phase II and phase III failures: 2013–2015 , 2016, Nature Reviews Drug Discovery.

[19]  A. T. Te Velde,et al.  Actual Usage and Quality of Experimental Colitis Models in Preclinical Efficacy Testing: A Scoping Review , 2016, Inflammatory bowel diseases.

[20]  R. Perlman,et al.  Mouse models of human disease , 2016, Evolution, medicine, and public health.

[21]  Jan Vanfleteren,et al.  Real-time monitoring of metabolic function in liver-on-chip microdevices tracks the dynamics of mitochondrial dysfunction , 2016, Proceedings of the National Academy of Sciences.

[22]  M Rowland,et al.  Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development , 2016, Clinical and translational science.

[23]  Jarrod Bailey,et al.  Non-human Primates in Neuroscience Research: The Case against its Scientific Necessity , 2016, Alternatives to laboratory animals : ATLA.

[24]  Robert L. Perlman,et al.  Mouse models of human disease evolutionary perspective , 2016 .

[25]  D. Fergusson,et al.  A meta-analysis of threats to valid clinical inference in preclinical research of sunitinib , 2015, eLife.

[26]  C. Little,et al.  On the predictive utility of animal models of osteoarthritis , 2015, Arthritis Research & Therapy.

[27]  R. M. Owen,et al.  An analysis of the attrition of drug candidates from four major pharmaceutical companies , 2015, Nature Reviews Drug Discovery.

[28]  Michael Schwarz,et al.  Real-time monitoring of oxygen uptake in hepatic bioreactor shows CYP450-independent mitochondrial toxicity of acetaminophen and amiodarone , 2015, Archives of Toxicology.

[29]  H. Würbel,et al.  Refinement of experimental design and conduct in laboratory animal research. , 2014, ILAR journal.

[30]  G. Langley.  Considering a new paradigm for Alzheimer's disease research. , 2014, Drug discovery today.

[31]  J. Cummings,et al.  Alzheimer’s disease drug-development pipeline: few candidates, frequent failures , 2014, Alzheimer's Research & Therapy.

[32]  R. Perera,et al.  The Need for Randomization in Animal Trials: An Overview of Systematic Reviews , 2014, PloS one.

[33]  Michael B Bracken,et al.  Is animal research sufficiently evidence based to be a cornerstone of biomedical research? , 2014, BMJ : British Medical Journal.

[34]  M. Endres,et al.  Found in translation: preclinical stroke research predicts human pathophysiology, clinical phenotypes, and therapeutic outcomes. , 2014, Stroke.

[35]  Ulrich Dirnagl,et al.  Distinguishing between Exploratory and Confirmatory Preclinical Research Will Improve Translation , 2014, PLoS biology.

[36]  S. Perrin.  Preclinical research: Make mouse studies work , 2014, Nature.

[37]  U. Dirnagl,et al.  Biomedical research: increasing value, reducing waste , 2014, The Lancet.

[38]  Michael Hay,et al.  Clinical development success rates for investigational drugs , 2014, Nature Biotechnology.

[39]  Published Online.  Biomedical research: increasing value, reducing waste , 2014 .

[40]  L. Hansen,et al.  Questions regarding the predictive value of one evolved complex adaptive system for a second: exemplified by the SOD1 mouse. , 2013, Progress in biophysics and molecular biology.

[41]  R. Perlman.  Evolution and Medicine , 2013, Perspectives in biology and medicine.

[42]  J. Aronson,et al.  Problems with using mechanisms to solve the problem of extrapolation , 2013, Theoretical Medicine and Bioethics.

[43]  J. Grimshaw,et al.  Threats to Validity in the Design and Conduct of Preclinical Efficacy Studies: A Systematic Review of Guidelines for In Vivo Animal Experiments , 2013, PLoS medicine.

[44]  M. Ritskes-Hoitinga,et al.  Progress in Using Systematic Reviews of Animal Studies to Improve Translational Research , 2013, PLoS medicine.

[45]  D. Howells,et al.  Evidence-based translational medicine. , 2013, Stroke.

[46]  Linda S. Birnbaum,et al.  Implementing Systematic Review at the National Toxicology Program: Status and Next Steps , 2013, Environmental health perspectives.

[47]  Leroy Hood,et al.  Systems Biology and P4 Medicine: Past, Present, and Future , 2013, Rambam Maimonides medical journal.

[48]  T. Miyakawa,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013 .

[49]  B. Vervliet,et al.  Criteria of validity in experimental psychopathology: application to models of anxiety and depression , 2012, Psychological Medicine.

[50]  D. Howells,et al.  Improving the Efficiency of the Development of Drugs for Stroke , 2012, International journal of stroke : official journal of the International Stroke Society.

[51]  Marlies Leenaars,et al.  Reducing the number of laboratory animals used in tissue engineering research by restricting the variety of animal models. Articular cartilage tissue engineering as a case study. , 2012, Tissue engineering. Part B, Reviews.

[52]  A. Buchan,et al.  Neuroprotection for Ischaemic Stroke: Translation from the Bench to the Bedside , 2012, International journal of stroke : official journal of the International Stroke Society.

[53]  Joseph Loscalzo,et al.  Personalized cardiovascular medicine and drug development: time for a new paradigm. , 2011, Circulation.

[54]  Monya Baker,et al.  Tissue models: A living system on a chip , 2011, Nature.

[55]  M. Macleod,et al.  Improving the translational hit of experimental treatments in multiple sclerosis , 2010, Multiple sclerosis.

[56]  H. Attarwala,et al.  TGN1412: From Discovery to Disaster , 2010, Journal of young pharmacists : JYP.

[57]  M. Mattson,et al.  “Control” laboratory rodents are metabolically morbid: Why it matters , 2010, Proceedings of the National Academy of Sciences.

[58]  Charles C. Persinger,et al.  How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.

[59]  D. Howells,et al.  Can Animal Models of Disease Reliably Inform Human Studies? , 2010, PLoS medicine.

[60]  H. Geerts.  Of Mice and Men , 2009, CNS drugs.

[61]  P. Glasziou,et al.  Avoidable waste in the production and reporting of research evidence , 2009, The Lancet.

[62]  Vincent J. Lynch,et al.  Use with caution: Developmental systems divergence and potential pitfalls of animal models , 2009, The Yale journal of biology and medicine.

[63]  U. Dirnagl,et al.  Empirical Evidence of Bias in the Design of Experimental Stroke Studies: A Metaepidemiologic Approach , 2008, Stroke.

[64]  R. Wall,et al.  Are animal models as good as we think? , 2008, Theriogenology.

[65]  D. Shaywitz,et al.  Found in translation , 2007, Nature Biotechnology.

[66]  D. Huitema.  Election manifestoes as the meeting point for experts and politicians in the Netherlands: the case of the National Institute for Public Health and the Environment (RIVM) , 2007 .

[67]  T. Preuss.  Who's afraid of Homo sapiens? , 2006, Journal of biomedical discovery and collaboration.

[68]  G. Donnan,et al.  1,026 Experimental treatments in acute stroke , 2006, Annals of neurology.

[69]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[70]  C. Hughes,et al.  Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.

[71]  John P A Ioannidis,et al.  Translation of highly promising basic science research into clinical applications. , 2003, The American journal of medicine.

[72]  A. Nagy,et al.  Mouse models of human disease , 2000, Clinical genetics.

[73]  A. Gray,et al.  I. THE ORIGIN OF SPECIES BY MEANS OF NATURAL SELECTION , 1963 .